Effects of Ketamine Infusion on Breathing and Encephalography in Spontaneously Breathing ICU Patients.

ICU sedation Ketamine infusion brain activity critical care ventilation inspiratory flow mechanical ventilation spontaneous breathing trial weaning from ventilator

Journal

Journal of intensive care medicine
ISSN: 1525-1489
Titre abrégé: J Intensive Care Med
Pays: United States
ID NLM: 8610344

Informations de publication

Date de publication:
Mar 2023
Historique:
pubmed: 9 8 2022
medline: 29 12 2022
entrez: 8 8 2022
Statut: ppublish

Résumé

Preclinical studies suggest that ketamine stimulates breathing. We investigated whether adding a ketamine infusion at low and high doses to propofol sedation improves inspiratory flow and enhances sedation in spontaneously breathing critically ill patients. In this prospective interventional study, twelve intubated, spontaneously breathing patients received ketamine infusions at 5 mcg/kg/min, followed by 10 mcg/kg/min for 1 h each. Airway flow, pressure, and esophageal pressure were recorded during a spontaneous breathing trial (SBT) at baseline, and during the SBT conducted at the end of each ketamine infusion regimen. SBT consisted of one-minute breathing with zero end-expiratory pressure and no pressure support. Changes in inspiratory flow at the pre-specified time points were assessed as the primary outcome. Ketamine-induced change in beta-gamma electroencephalogram power was the key secondary endpoint. We also analyzed changes in other ventilatory parameters respiratory timing, and resistive and elastic inspiratory work of breathing. Ketamine infusion of 5 and 10 mcg/kg/min increased inspiratory flow (median, IQR) from 0.36 (0.29-0.46) L/s at baseline to 0.47 (0.32-0.57) L/s and 0.44 (0.33-0.58) L/s, respectively ( In intubated, spontaneously breathing patients receiving a constant rate of propofol, ketamine increased inspiratory flow, reduced inspiratory work of breathing, and was associated with an "activated" electroencephalographic pattern. These characteristics might facilitate weaning from mechanical ventilation.

Sections du résumé

BACKGROUND BACKGROUND
Preclinical studies suggest that ketamine stimulates breathing. We investigated whether adding a ketamine infusion at low and high doses to propofol sedation improves inspiratory flow and enhances sedation in spontaneously breathing critically ill patients.
METHODS METHODS
In this prospective interventional study, twelve intubated, spontaneously breathing patients received ketamine infusions at 5 mcg/kg/min, followed by 10 mcg/kg/min for 1 h each. Airway flow, pressure, and esophageal pressure were recorded during a spontaneous breathing trial (SBT) at baseline, and during the SBT conducted at the end of each ketamine infusion regimen. SBT consisted of one-minute breathing with zero end-expiratory pressure and no pressure support. Changes in inspiratory flow at the pre-specified time points were assessed as the primary outcome. Ketamine-induced change in beta-gamma electroencephalogram power was the key secondary endpoint. We also analyzed changes in other ventilatory parameters respiratory timing, and resistive and elastic inspiratory work of breathing.
RESULTS RESULTS
Ketamine infusion of 5 and 10 mcg/kg/min increased inspiratory flow (median, IQR) from 0.36 (0.29-0.46) L/s at baseline to 0.47 (0.32-0.57) L/s and 0.44 (0.33-0.58) L/s, respectively (
CONCLUSIONS CONCLUSIONS
In intubated, spontaneously breathing patients receiving a constant rate of propofol, ketamine increased inspiratory flow, reduced inspiratory work of breathing, and was associated with an "activated" electroencephalographic pattern. These characteristics might facilitate weaning from mechanical ventilation.

Identifiants

pubmed: 35934953
doi: 10.1177/08850666221119716
doi:

Substances chimiques

Ketamine 690G0D6V8H
Propofol YI7VU623SF

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

299-306

Auteurs

Aiman Suleiman (A)

Department of Anesthesia, Critical Care & Pain Medicine, 1859Beth Israel Deaconess Medical Center, 1811Harvard Medical School, Boston, MA, USA.
Center for Anesthesia Research Excellence (CARE), 1859Beth Israel Deaconess Medical Center, Boston, MA, USA.
Department of Anesthesia and Intensive Care, Faculty of Medicine, University of Jordan, Amman, Jordan.

Peter Santer (P)

Department of Anesthesia, Critical Care & Pain Medicine, 1859Beth Israel Deaconess Medical Center, 1811Harvard Medical School, Boston, MA, USA.

Ronny Munoz-Acuna (R)

Department of Anesthesia, Critical Care & Pain Medicine, 1859Beth Israel Deaconess Medical Center, 1811Harvard Medical School, Boston, MA, USA.

Maximilian Hammer (M)

Department of Anesthesia, Critical Care & Pain Medicine, 1859Beth Israel Deaconess Medical Center, 1811Harvard Medical School, Boston, MA, USA.

Maximilian S Schaefer (MS)

Department of Anesthesia, Critical Care & Pain Medicine, 1859Beth Israel Deaconess Medical Center, 1811Harvard Medical School, Boston, MA, USA.
Center for Anesthesia Research Excellence (CARE), 1859Beth Israel Deaconess Medical Center, Boston, MA, USA.
Department of Anesthesiology, Duesseldorf University Hospital, Germany.

Luca J Wachtendorf (LJ)

Department of Anesthesia, Critical Care & Pain Medicine, 1859Beth Israel Deaconess Medical Center, 1811Harvard Medical School, Boston, MA, USA.
Center for Anesthesia Research Excellence (CARE), 1859Beth Israel Deaconess Medical Center, Boston, MA, USA.
Department of Anesthesiology, 2013Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA.

Sandra Rumyantsev (S)

Pharmacy, 1859Beth Israel Deaconess Medical Center, 1811Harvard Medical School, Boston, MA, USA.

Lorenzo Berra (L)

Department of Anesthesia, Critical Care and Pain Medicine, 2348Massachusetts General Hospital, 1811Harvard Medical School, Boston, MA, USA.

Shubham Chamadia (S)

Department of Anesthesia, Critical Care and Pain Medicine, 2348Massachusetts General Hospital, 1811Harvard Medical School, Boston, MA, USA.

Oluwaseun Johnson-Akeju (O)

Department of Anesthesia, Critical Care and Pain Medicine, 2348Massachusetts General Hospital, 1811Harvard Medical School, Boston, MA, USA.
McCance Center for Brain Health, 2348Massachusetts General Hospital, 1811Harvard Medical School, Boston, MA, USA.

Elias N Baedorf-Kassis (EN)

Department of Medicine, Division of Pulmonary and Critical Care, 1859Beth Israel Deaconess Medical Center, 1811Harvard Medical School, Boston, MA, USA.

Matthias Eikermann (M)

Department of Anesthesiology, 2013Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA.
Klinik für Anästhesiologie und Intensivmedizin, Universität Duisburg-Essen, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH